EMMPRIN expression is involved in the development of interstitial fibrosis and tubular atrophy in human kidney allografts
- PMID: 26659824
- DOI: 10.1111/ctr.12677
EMMPRIN expression is involved in the development of interstitial fibrosis and tubular atrophy in human kidney allografts
Abstract
Background: Matrix metalloproteinases (MMP) are involved in the development of interstitial fibrosis and tubular atrophy (IF/TA) in renal disease. The synthesis of MMP is activated by the extracellular matrix metalloproteinases inducer protein (EMMPRIN). To analyze the role of EMMPRIN in IF/TA, we retrospectively detected EMMPRIN expression in specimens of human renal allografts with various levels of IF/TA.
Methods: Immunohistochemistry was performed to detect EMMPRIN expression. In a retrospective analysis, a total cohort of 50 specimens were divided according to BANFF-classification into four subgroups (0-3): no, mild (≤ 25%), moderate (26-50%), or severe (>50%) IF/TA. Among other parameters, renal function was analyzed and compared to EMMPRIN expression.
Results: In 24 of 38 biopsies, we detected positive EMMPRIN staining. All nephrectomy (n = 12) samples were negative for EMMPRIN. Positive staining in the biopsy samples was detectable on the basolateral side of tubular epithelial cells. EMMPRIN staining was negatively correlated with IF/TA (p < 0.001). We found significant differences between the mean EMMPRIN expression in IF/TA groups 0 and 3 (p = 0.021) and groups 1 and 3 (p = 0.004). Furthermore, we found significant correlations between EMMPRIN staining and renal function.
Conclusion: Our data suggest that EMMPRIN is involved in the pathophysiology of IF/TA.
Keywords: CD147/basigin; chronic allograft dysfunction; extracellular matrix metalloproteinases inducer; interstitial fibrosis and tubular atrophy; kidney transplantation; matrix metalloproteinases.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Screening of vesicoureteral reflux in pediatric patients with kidney transplantation showing non-specific interstitial fibrosis and tubular atrophy with interstitial Tamm-Horsfall protein deposits in protocol allograft biopsy.Clin Transplant. 2009 Aug;23 Suppl 20:2-5. doi: 10.1111/j.1399-0012.2009.01000.x. Clin Transplant. 2009. PMID: 19594587
-
Expression of bone morphogenetic proteins 4, 6 and 7 is downregulated in kidney allografts with interstitial fibrosis and tubular atrophy.Int Urol Nephrol. 2015 Jul;47(7):1219-29. doi: 10.1007/s11255-015-0993-1. Epub 2015 May 12. Int Urol Nephrol. 2015. PMID: 25962604
-
Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.Nephrol Dial Transplant. 2009 Aug;24(8):2567-75. doi: 10.1093/ndt/gfp183. Epub 2009 Apr 27. Nephrol Dial Transplant. 2009. PMID: 19398767
-
Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?Curr Opin Nephrol Hypertens. 2014 May;23(3):245-50. doi: 10.1097/01.mnh.0000444811.26884.2d. Curr Opin Nephrol Hypertens. 2014. PMID: 24626060 Review.
-
Expression and role of integrin-linked kinase and collagen IV in human renal allografts with interstitial fibrosis and tubular atrophy.Transpl Immunol. 2010 May;23(1-2):1-5. doi: 10.1016/j.trim.2010.04.001. Epub 2010 Apr 14. Transpl Immunol. 2010. PMID: 20398767 Review.
Cited by
-
Bone Morphogenetic Proteins (BMPs), Extracellular Matrix Metalloproteinases Inducer (EMMPRIN), and Macrophage Migration Inhibitory Factor (MIF): Usefulness in the Assessment of Tubular Dysfunction Related to Chronic Kidney Disease (CKD).J Clin Med. 2021 Oct 23;10(21):4893. doi: 10.3390/jcm10214893. J Clin Med. 2021. PMID: 34768412 Free PMC article.
-
The Effects of EMMPRIN/CD147 on Late Function and Histopathological Lesions of the Renal Graft.Biology (Basel). 2022 Feb 1;11(2):232. doi: 10.3390/biology11020232. Biology (Basel). 2022. PMID: 35205098 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous